Mind Medicine (Mind Medicine) FCF Yield % : -9.82 (As of May. 11, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mind Medicine FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Mind Medicine's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $0.00 Mil. Therefore, Mind Medicine's FCF Yield % for today is -9.82%.

The historical rank and industry rank for Mind Medicine's FCF Yield % or its related term are showing as below:

MMCWF' s FCF Yield % Range Over the Past 10 Years
Min: -652.23 Med: 0 Max: 0
Current: -9.82

MMCWF's FCF Yield % is ranked better than
58.03% of 1556 companies
in the Biotechnology industry
Industry Median: -14.17 vs MMCWF: -9.82

Mind Medicine's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Mind Medicine FCF Yield % Historical Data

The historical data trend for Mind Medicine's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine FCF Yield % Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Mind Medicine Quarterly Data
	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Mind Medicine's FCF Yield %

For the Biotechnology subindustry, Mind Medicine's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mind Medicine's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mind Medicine's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Mind Medicine's FCF Yield % falls into.

Mind Medicine FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Mind Medicine's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-64.365	/
	=	N/A%

Mind Medicine's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-20.563	*	4	/
	=	N/A%

Mind Medicine FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Mind Medicine FCF Yield % Related Terms

Thank you for viewing the detailed overview of Mind Medicine's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mind Medicine (Mind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (OTCPK:MMCWF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

MNMD:USA MMQ:Germany MMED:Canada

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.